D Walmrath
Overview
Explore the profile of D Walmrath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hecker M, Sommer N, Hecker A, Bandorski D, Weigand M, Krombach G, et al.
Anaesthesist
. 2017 Feb;
66(3):211-226.
PMID: 28204834
Pulmonary embolism is a potentially fatal disorder and frequently seen in critical care and emergency medicine. Due to a high mortality rate within the first few hours, the accurate initiation...
2.
Hecker M, Sommer N, Hecker A, Bandorski D, Weigand M, Krombach G, et al.
Med Klin Intensivmed Notfmed
. 2015 Dec;
111(2):163-75.
PMID: 26621816
Pulmonary embolism is a potentially fatal disorder and frequently seen in critical care and emergency medicine. Due to a high mortality rate within the first few hours, the accurate initiation...
3.
Gunther A, Walmrath D, Grimminger F, Seeger W
Semin Respir Crit Care Med
. 2005 Aug;
22(3):247-58.
PMID: 16088677
The acute respiratory distress syndrome (ARDS) is a life-threatening syndrome that may occur in any patient without any predisposition and that is mostly triggered by underlying processes such as sepsis,...
4.
Schermuly R, Leuchte H, Ghofrani H, Weissmann N, Rose F, Kohstall M, et al.
Eur Respir J
. 2003 Sep;
22(2):342-7.
PMID: 12952271
In this study, the impact of aerosolised prostacyclin (PGI2) and iloprost in the absence or presence of subthreshold intravascular doses of the dual-selective phosphodiesterase-3/4 inhibitor zardaverine was investigated in an...
5.
Walmrath D, Grimminger F, Pappert D, Knothe C, Obertacke U, Benzing A, et al.
Eur Respir J
. 2002 May;
19(5):805-10.
PMID: 12030717
The aim of the present study was to investigate the feasibility and efficacy of bronchoscopic surfactant administration in a noncontrolled multicentre study in five university centres. A total number of...
6.
Gunther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, et al.
Eur Respir J
. 2002 May;
19(5):797-804.
PMID: 12030716
The purpose of the present study was to investigate the impact of bronchoscopic surfactant administration, on the biochemical and biophysical surfactant properties, in patients with severe and early acute respiratory...
7.
Walmrath D, Grimminger F, Seeger W
Internist (Berl)
. 2002 Jan;
42(12):1619-20, 1623-30.
PMID: 11793601
No abstract available.
8.
Olschewski H, Rose F, Grunig E, Ghofrani H, Walmrath D, Schulz R, et al.
J Lab Clin Med
. 2001 Dec;
138(6):367-77.
PMID: 11753283
The identification of several mutations of the bone morphogenetic protein receptor 2 (BMPR2) gene, a member of the transforming growth factor beta receptor family, gives hope for new insights into...
9.
Gunther A, Ruppert C, Schmidt R, Markart P, Grimminger F, Walmrath D, et al.
Respir Res
. 2001 Dec;
2(6):353-64.
PMID: 11737935
The acute respiratory distress syndrome (ARDS) is a frequent, life-threatening disease in which a marked increase in alveolar surface tension has been repeatedly observed. It is caused by factors including...
10.
Schermuly R, Krupnik E, Tenor H, Schudt C, Weissmann N, Rose F, et al.
Am J Respir Crit Care Med
. 2001 Nov;
164(9):1694-700.
PMID: 11719312
Inhalation of aerosolized iloprost, a stable prostacyclin analog, has been suggested for treatment of primary and secondary pulmonary hypertension, but demands multiple daily inhalation maneuvers because of the short-term effect...